Results 11 to 20 of about 7,684 (214)

Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings

open access: yesJIMD Reports, 2021
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder of bile acid synthesis caused by pathogenic variants in the CYP27A1 gene encoding the mitochondrial enzyme sterol 27‐hydroxylase.
Adam J. Guenzel   +3 more
doaj   +2 more sources

Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis

open access: yesFrontiers in Pediatrics, 2020
Background: Cerebrotendinous xanthomatosis (CTX) is an inborn disorder of bile acid synthesis which causes progressive accumulation of toxic metabolites in various organs, particularly in brain and tendons.
Irene Degrassi   +7 more
doaj   +2 more sources

Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Cerebrotendinous xanthomatosis (CTX) is a rare inborn lipid-storage disease caused by mutations in the sterol 27-hydroxylase (CYP27A1) gene with an autosomal recessive pattern of inheritance. To date, only 19 CTX patients from 16 families have
Qing-Qing Tao   +5 more
doaj   +2 more sources

Clinical features and genetic analysis of a Brazilian patient with sitosterolemia: a case report [PDF]

open access: yesArchives of Endocrinology and Metabolism
Sitosterolemia is a rare genetic lipid disorder caused by mutations in the ABCG5/ABCG8, genes. It is characterized by plasmatic plant sterols accumulation, formation of tendon and tuberous xanthomas and early onset coronary artery disease.
Felipe Augusto Azevedo Leão   +3 more
doaj   +2 more sources

Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis

open access: yesOrphanet Journal of Rare Diseases, 2023
Background Cerebrotendinous xanthomatosis (CTX) is a rare recessive genetic disease characterized by disruption of bile acid synthesis due to inactivation of the CYP27A1 gene. Treatment is available in the form of bile acid replacement.
T. Pramparo   +3 more
semanticscholar   +1 more source

Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Cerebrotendinous xanthomatosis (CTX) is a rare, chronic, progressive, neurodegenerative disorder requiring life-long care. Patients with CTX often experience a diagnostic delay.
B. Stelten   +13 more
semanticscholar   +1 more source

Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity

open access: yesClinical Case Reports, 2023
Familial hypercholesterolemia (FH) is a rare but life‐threatening disorder. Skin manifestations can be its only manifestation. We present a case of a fifteen‐year‐old female child, with multiple eruptive xanthomas, xanthomas anarcus, and a deranged lipid
Amal Chamli   +4 more
doaj   +1 more source

Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments

open access: yesJournal of atherosclerosis and thrombosis, 2021
Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive lipid storage disorder caused by mutations in the CYP27A1 gene, which encodes the mitochondrial enzyme sterol 27-hydroxylase. Decreased sterol 27-hydroxylase activity results in impaired bile
Shingo Koyama   +6 more
semanticscholar   +1 more source

Long-term MRI Findings in Patients With Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid

open access: yesNeurology, 2022
Objectives To describe long-term follow-up brain MRI findings in patients with cerebrotendinous xanthomatosis (CTX) treated with chenodeoxycholic acid (CDCA).
B. Stelten   +5 more
semanticscholar   +1 more source

A clinical case of secondary xanthomatosis in a patient with biliary cirrhosis

open access: yesЛечащий Врач, 2021
The article describes the clinical manifestations of secondary xanthomatosis in a 46-year-old patient with primary biliary cirrhosis who was consulted by a dermatovenerologist.
N. V. Zilberberg   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy